LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation
Authors:
Open Access
- 26 March 2020
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 18 (1) , 1-13
Abstract
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent cancers worldwide. Due to its high morbidity and mortality rates, it is urgent to find a molecular target that contributes to esophageal carcinogenesis and progression. In this research, we aimed to investigate the functions of Latent transforming growth factor β binding protein 1(LTBP1) in ESCC progression and elucidate the underlying mechanisms. Methods: The tandem mass tag-based quantitative proteomic approach was applied to screen the differentially expressed proteins (DEPs) between 3 cases of ESCC tumor samples and paired normal tissues. Then the DEPs were validated in human ESCC tissues using western blot assays and GEPIA database respectively. The expression level of LTBP1 was detected in 152 cases of ESCC tissues and paired normal tissues. Loss-of-function assays were performed to detect the function of LTBP1 in vivo and in vitro. Immunofluorescence and Western blot assays were used to detect the expression of apoptosis, epithelial–mesenchymal transition (EMT) and cancer-associated fibroblasts (CAFs) markers. Results: A total of 39 proteins were screened to be up-regulated (ratio > 2.0) in all three ESCC tissues. The results of immunohistochemistry assays indicated that the expression level of LTBP1 was higher in ESCC tissues than that in paired normal tissues (p < 0.001). Overexpression of LTBP1 was positively associated with lymphatic metastasis in ESCC (p = 0.002). Down-regulation of LTBP1 inhibited the invasion and migration as well as metastatic abilities in vitro and in vivo. It was also observed the down-regulation of LTBP1 not only decreased the mesenchymal phenotypes but also inhibited TGFβ-induced EMT in ESCC cells. We further found that down-regulation of LTBP1 enhanced ESCC cells’ sensitivity to 5-FU treatment. Inhibition of LTBP1 expression could also attenuate induction of CAFs transformation and restrain fibroblast express fibronectin (FN1) in ESCC cells. Conclusion: Overexpression of LTBP1 was associated with lymph node metastasis in ESCC. Our results indicated that LTBP1 not only increased the malignant behaviors of ESCC cells but also induced EMT and CAFs transformation. Our studies suggested an oncogenic role of LTBP1 in ESCC progression and it may serve as a potential therapeutic target for ESCC patients.Keywords
Funding Information
- National Natural Science Foundation of China (81672441)
- Natural Science Foundation of Guangdong Province (2016A030313580, 2017A030313607)
This publication has 42 references indexed in Scilit:
- Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancerOncology Reports, 2013
- Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomasCellular Oncology, 2011
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- Modulation of TGF‐β activity by latent TGF‐β‐binding protein 1 in human malignant glioma cellsInternational Journal of Cancer, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Lung metastasis genes couple breast tumor size and metastatic spreadProceedings of the National Academy of Sciences, 2007
- Novel Functional Single Nucleotide Polymorphisms in the Latent Transforming Growth Factor-β Binding Protein-1L PromoterThe Journal of Molecular Diagnostics, 2006
- New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resectionBest Practice & Research Clinical Gastroenterology, 2006
- Evidence for the Decreased Expression of the Latent TGF-β Binding Protein and its Splice Form in Human Liver TumoursScandinavian Journal of Gastroenterology, 2001
- Assignment of the gene encoding the latent TGF-β1-binding protein (LTBP1) to human chromosome 2, region p12→q22Cytogenetic and Genome Research, 1994